BCD-085

· Biocad

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for BCD-085, covering 2016-05-23 to 2025-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritis [Phase 3]

See pricing